LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
57 hedge funds and large institutions have $37M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
–
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
10
Closed
11
Calls
$5K
Puts
$32K
Net Calls
-$27K
Net Calls Change
+$16K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$1.18M |
| 2 |
2
Millennium Management
New York
|
$312K |
| 3 |
SC
3
Samlyn Capital
New York
|
$3.49M |
| 4 |
4
William Blair & Company
Chicago,
Illinois
|
$51K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$43K |
Top Sellers
| 1 |
LPC
1
Lion Point Capital
New York
|
$0 |
| 2 |
E
2
Ergoteles
New York
|
$0 |
| 3 |
3
Renaissance Technologies
New York
|
$0 |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$0 |
